ClinicalTrialsFinder
RecruitingNot ApplicableNCT06427954

Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer

Randomized Trial of Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer

Sponsor

Massachusetts General Hospital

Enrollment

250 participants

Start Date

Aug 6, 2024

Study Type

INTERVENTIONAL

Conditions

Lung Cancer

Summary

Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Adults (greater than or equal to 18 years)
  • Diagnosed with advanced non-small cell lung cancer (NSCLC) that is not being treated with curative intent or extensive stage small cell lung cancer (SCLC) within the past 12 weeks.
  • Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) = 0-2 (i.e., fully active to at least ambulatory and up and about more than 50% of waking hours).
  • Sufficient English proficiency to utilize THRIVE in English (Note: patients can complete outcome measures in Spanish if preferred).

Exclusion Criteria1

  • Significant uncontrolled psychiatric disorder (e.g., psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the ability to participate in study procedures.

Interventions

BEHAVIORALDigital Health App

access to a digital health app

Locations(3)

University of California Los Angeles

Los Angeles, California, United States

Veteran Affairs Greater Los Angeles Health Care

Los Angeles, California, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06427954

Related Trials

Virtual Agent Feasibility in Oncology Patients (NTT Data)

NCT066820131 location

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

NCT046786483 locations

Study of Novel Treatment Combinations in Patients With Lung Cancer

NCT05633667100 locations

Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device

NCT062954971 location

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT0661828763 locations